Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug1027 | Cocoa extract Wiki | 1.00 |
drug4072 | Standard Care Therapy Wiki | 1.00 |
drug2695 | Multivitamin placebo Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0001626 | Abnormality of the cardiovascular system HPO | 0.16 |
Navigate: Correlations HPO
There is one clinical trial.
The purpose of this study is to determine whether taking daily, dietary supplements of cocoa extract (containing cocoa flavanols and theobromine from the cocoa bean) and/or a standard multivitamin reduces the risk of developing cardiovascular disease (including heart attack, stroke, coronary revascularization, unstable angina or acute coronary syndrome (ACS) requiring hospitalization, carotid artery surgery, and peripheral artery surgery or angioplasty, and cardiovascular mortality) and cancer.
Description: CVD events include myocardial infarction, stroke, cardiovascular deaths, coronary revascularization procedures, unstable angina or ACS requiring hospitalization, carotid artery surgery, and peripheral artery surgery or angioplasty. CVD events are confirmed by review of discharge summaries, ECG's, laboratory reports, test reports, radiology reports, surgical reports, medical records for reports of increased pain, use of medication to alleviate pain, and evidence of troponin leak, and death certificates.
Measure: Cardiovascular disease (CVD) events Time: 5 yearsDescription: Diagnoses of invasive cancer are confirmed by review of discharge summaries, pathology reports, operative reports, surgical reports, and diagnostic or treatment procedure reports, including both inpatient and outpatient procedures.
Measure: Invasive cancer Time: 5 yearsDescription: Assessed by pulse wave analysis
Measure: Pulse wave velocity and central blood pressure indices Time: 2 yearsDescription: Balance tests, grip strength, timed chair stands, walking speed
Measure: Physical performance Time: 2 yearsDescription: Assessed by dual x-ray absorptiometry
Measure: Bone mass density in hip, spine, and total body, and body composition Time: 2 yearsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports